Portfolio
•
Jan 30th, 2025

Why we invested in ORamaVR

Computational Medical Extended Reality that lets clinicians rehearse procedures before they reach the operating room.

Healthcare systems need to train more clinicians, faster, on procedures that keep getting more complex, from new implants to surgical robots. Yet the classic "see one, do one" model is hard to scale, depends on access to cases and mentors, and means the first real attempt often happens on a real patient. Physical simulators help, but they are expensive, bulky and limited to a few scenarios.

ORamaVR has created Computational Medical Extended Reality (CMXR), a category of software that blends virtual reality with AI, medical knowledge, digital twins of surgical robots and real-time performance analytics. Clinicians practise procedures in realistic, repeatable simulations on standard XR headsets, and institutions and device makers can build their own training modules on ORamaVR's platform rather than commissioning each one from scratch. Studies cited by the company show fewer errors and better clinical skills after training.

Software scales where physical simulators cannot, and ORamaVR's platform approach means every new procedure adds to a growing library instead of starting over. The company has also sharpened its focus on a clear buyer: medical device and surgical robot manufacturers who must train clinicians on every new product they launch.

Above all, we invested in the people. CEO George Papagiannakis is a professor of computer graphics at the University of Crete, earned his PhD at the University of Geneva and is deputy director of the Human-Computer Interaction Lab at the FORTH research centre, where ORamaVR began. Chief Medical Officer Eleftherios Tsiridis, a professor of orthopaedics at Aristotle University of Thessaloniki, brings the surgeon's view, and Chief Robotics Officer Panos Trahanias, a professor at the University of Crete and FORTH, brings decades of robotics research. We believed a team combining graphics, surgery and robotics at this level could define an entirely new category of medical software.